ImmunoGen Message Board - Msg: 32504845

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gary Mohilner who wrote (5634)	1/15/2020 3:02:16 PM
From: Wildbiftek	Read Replies (1) of 5665

It's unlikely that they will announce a transformative deal, but they might provide some color on how they will finance the bevy of new trials through readout that they have planned: investor.immunogen.com The structure of any deal hopefully doesn't give up too much ownership of Mirvetuxemab S. prior to the readout of SORAYA.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next